Extends HeartBeam’s reach with FDA-cleared Halo+ atrial fibrillation detection system and physician-prescribed integrated patient care platform
News | ECG
HeartBeam Announces Acquisition of LIVMOR Assets Extending Reach with FDA-cleared Halo+ Atrial Fibrillation Detection System

March 27, 2023 — HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector ...

Home March 27, 2023
Home
An analysis based on the EAST – AFNET 4 trial
News | Atrial Fibrillation
Is Early Rhythm Control in Atrial Fibrillation Care Cost-effective?

March 27, 2023 — Patients with atrial fibrillation (AF) benefit from early rhythm control therapy. It reduces ...

Home March 27, 2023
Home
The recalled product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
News | Antiplatelet and Anticoagulation Therapies
Ascend Laboratories Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules Due to the Detection of NDMA Impurity

March 24, 2023 — According to the U.S. Food and Drug Administration (FDA), Ascend Laboratories LLC is voluntarily ...

Home March 24, 2023
Home
CardioMEMS is a tiny implantable sensor that can remotely flag early warning signs of worsening heart failure
News | Heart Failure
New Data Show Remote Monitoring Technology Like Abbott’s Cardiomems Helps Improve Survival in Heart Failure Patients

March 24, 2023 — Abbott announced new data that found monitoring patients remotely with hemodynamic pressure sensing ...

Home March 24, 2023
Home
The Vascular Verification Program establishes a cohesive framework for hospitals focused on using data and quality improvement practices to deliver appropriate clinical care to achieve optimal vascular patient outcomes
News | Cardiovascular Surgery
The American College of Surgeons and the Society for Vascular Surgery Launch National Quality Verification Program for Vascular Care

March 24, 2023 — The American College of Surgeons (ACS), with the Society for Vascular Surgery (SVS), has launched a new ...

Home March 24, 2023
Home
News | Cardiovascular Clinical Studies
Clinical Trial of Investigational Vaccine to Treat LDL Cholesterol Underway

March 24, 2023 — Vaxxinity, Inc., a Cape Canaveral, FL-based company pioneering the development of a new class of ...

Home March 24, 2023
Home
AiMed Summit 2023
Feature | AIMed | By Melinda Taschetta-Millane
AiMed 2023: Changing Healthcare One Connection at a Time

The 2023 AiMed Global Summit will focus on artificial intelligence (AI) in healthcare, and will offer valuable insights ...

Home March 23, 2023
Home
A newly-published study in the European Society of Cardiology’s European Heart Journal is shedding new light on the obesity paradox.
News | ESC
Study Puts ‘Obesity Paradox’ in Spotlight: Waist-to-height Ratio Better Than BMI as Indicator of Outcomes in Patients with Heart Failure

March 23, 2023 — Newly-published research has debunked the idea that there is an “obesity paradox,” whereby patients ...

Home March 23, 2023
Home
New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms
News | Artificial Intelligence
Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm

March 22, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced it ...

Home March 22, 2023
Home
New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms
News | Artificial Intelligence
Brainomix Receives FDA Clearance for Its Flagship Stroke AI Imaging Software

March 22, 2023 — Brainomix, the AI-powered medtech solutions company, today announced that its Brainomix 360 e-ASPECTS ...

Home March 22, 2023
Home
New Patent Adds to the Istaroxime Patent Estate and Provides Intellectual Property Protection Until Late 2039
News | Cardiogenic Shock
Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office

March 22, 2023 — Windtree Therapeutics, Inc., a biotechnology company focused on advancing multiple late-stage ...

Home March 22, 2023
Home
News | Cardiovascular Clinical Studies
Clinical Science Session at THT 2023 Presents 12-month Data on AccuCinch Ventricular Restoration System for Heart Failure Patients with HFrEf

March 22, 2023 — Ancora Heart, Inc., a privately-held Santa Clara, CA-based company developing a completely ...

Home March 22, 2023
Home
Top priorities of the American College of Cardiology (ACC) for the coming year were recently highlighted by its new president, B. Hadley Wilson, MD, during the Convocation held at the close of the 3-day ACC Annual Scientific Sessions.
News | ACC
New ACC President Defines Priorities for Year Ahead

March 21, 2023 — As part of its extensive coverage, the editorial team at dicardiology.com/DAIC has shared summary ...

Home March 21, 2023
Home
Late-breaking data presented at THT shows substantial fluid loss and improvements in kidney and cardiac function at 30 days after Aortix therapy
News | Heart Failure
Aortix Pump Therapy Leads to Rapid Decongestion and Improved Kidney Function in Hospitalized Patients with Heart Failure and Worsening Renal Function

March 21, 2023 — Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and ...

Home March 21, 2023
Home
The full results of BeAT-HF, including a number of additional analyses and endpoints, will be submitted by the executive steering committee for publication in one or more peer-reviewed journals
News | Heart Failure
Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

March 21, 2023 — CVRx, Inc., a commercial-stage medical device company focused on developing, manufacturing and ...

Home March 21, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now